Blast crisis in myelogenous leukaemia and Chronic myeloid leukaemia

---

Gender of people who have Blast Crisis In Myelogenous Leukaemia and experienced Chronic Myeloid Leukaemia *:

• female: 40 %
• male: 60 %

Age of people who have Blast Crisis In Myelogenous Leukaemia and experienced Chronic Myeloid Leukaemia *:

• 0-1: 0.0 %
• 2-9: 0.0 %
• 10-19: 0.0 %
• 20-29: 0.0 %
• 30-39: 0.0 %
• 40-49: 30 %
• 50-59: 20 %
• 60+: 50 %

Common co-existing conditions for these people *:

1. Hyperglycemia (high blood sugar): 1 person, 6.25%
2. Drug Resistance (reduction in effectiveness of a drug): 1 person, 6.25%
3. Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 1 person, 6.25%

Common drugs taken by these people *:

1. Gleevec: 6 people, 37.50%
2. Tasigna: 4 people, 25.00%
3. Iclusig: 3 people, 18.75%
4. Glivec: 3 people, 18.75%
5. Cytarabine: 3 people, 18.75%
6. Sprycel: 2 people, 12.50%
7. Prednisolone: 2 people, 12.50%
8. Oncovin: 2 people, 12.50%
9. Bosulif: 2 people, 12.50%
10. Pravachol: 1 person, 6.25%

Common symptoms for these people *:

1. Malignant Neoplasm Progression (cancer tumour came back): 6 people, 37.50%
2. Drug Resistance (reduction in effectiveness of a drug): 5 people, 31.25%
3. White Blood Cell Count Increased: 4 people, 25.00%
4. Fatigue (feeling of tiredness): 3 people, 18.75%
5. Pneumonia: 3 people, 18.75%
6. Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 2 people, 12.50%
7. Blast Cell Count Increased: 2 people, 12.50%
8. Bone Marrow Depression (decreased ability or inability of the bone marrow to produce blood cells): 2 people, 12.50%
9. Fever: 2 people, 12.50%
10. Gastric Ulcer (stomach ulcer): 2 people, 12.50%

Do you take medications and have Chronic myeloid leukaemia?

- Check whether Chronic myeloid leukaemia is associated with a drug or a condition